If you want to know Bionaturis Group latest news, here you are our May Newsletter

Imagen Bionaturis Newsletter


  • Bionaturis Group increased 29% EBITDA in full year 2014 results
  • Bionaturis Group takes part in the European Forum for the Innovation in the Marine Bioresources

Let’s get to know…

Arantza Muriana Miralles, 39 years old, born in San Sebastian. Degree in Pharmaceutical Sciences by Navarra University, Master in Pharmaceutical Chemistry and MBA.



Arantza Muriana

  • -When you were a child, what did you want to be as an adult?
  • A teacher, a researcher, a doctor… depending on the age I was.
  • -What do you like the most about your job?
  • A lot of things: the contact with people from different origins and cultures, the possibility of travelling to very varied places, knowing that with our work we are contributing to have safer and more efficient medicines…
  • -What are your future challenges?
  • To access into the cosmetic industry and personal care products, which must be also safe products although we aren’t so conscious of that. And to consolidate our company in both agrochemical and petrochemical markets.
  • -Your favourite dish
  • Scrambled eggs with recently harvested mushrooms.
  • -A place
  • Everyone near the sea, such as El Peine de los Vientos in San Sebastian, or La Barra in Orio.
  • -A film
  • ‘Fried Green Tomatoes’
  • -A historical figure
  • Marie Curie.
  • -A book
  • ‘Earth’s Children’, by Jean M. Auel.
  • -A song
  • ‘Baby can I hold you’, by Tracy Chapman.
  • -What do you usually do in your free time?
  • Going to the mountains or to the beach to have a walk with my familiy and my pet, reading, watching films…
  • -You can’t live without…
  • My daugthers and her hugs.
  • -How do you imagine the world in 20 years?
  • With a lot of technological progress that will improve our quality of life, but I hope they won’t reduce our humanity.
  Arantza is founder and R+D Manager Director at BBD BioPhenix (previously, Biobide), belonged to Bionaturis Group, since February, 2006.

Bionaturis Group increased 29% EBITDA in full year 2014 results

Bionaturis Group, Spanish biopharmaceutical Group (ticker BNT) focusing its activity on the development of biological medicines for human and animal health, has reached in year 2014 €931.000 of EBITDA in full year 2014 results, increased of 29% compared with last year. Bionaturis Group Net Income was €1.19 million in 2014, a growth of 152 % compared to the same period of the previous year. Furthermore, the total amount of income was €3.03 million, which means an increase of 73% compared to the last year. This increase is basically due to the rise of net sales in 116% compared to 2013 […] Read more

Bionaturis Group takes part in the European Forum for the Innovation in the Marine Bioresources

Bionaturis Group took part recently in the final event of the European Forum for the innovation in the Marine Bioresources AtlanticBlueTech Project, hold in CEEI Bahia de Cadiz. Representatives of the institutions and companies included in the project from Portugal, United Kingdom and Ireland, among other countries, attended this top-level international forum. Ana de las Heras, PhD in Veterinarian Sciences and Project Manager at Bionaturis, was the person in charge of explaining the work of the company and the advantages of our platform Flylife for the development and production of biological medicines. In addition, a group of members of Oceano XXI (Cluster do Mar in Portugal, partners of Atlantic BlueTech Project) visited Bionaturis’ facilities in Jerez to know at firsthand how the company is applying innovation in this field […] Read more


Relevant info: Complement to the 2014 Annual Report and typos

Financial Information: 2014 Annual Report

Hi, this newsletter contains information about my website. For any question, please contact to info@bionaturis.com
Imagen Boletín Bionaturis Imagen Twitter Bionaturis Imagen Linked In Bionaturis Imagen Flickr Bionaturis Imagen Youtube Bionaturis Imagen Blog Bionaturis
Este e-mail ha sido enviado por *|EMAIL|*¿Por qué me sale esto?    No quiero seguir recibiendo este newsletter    Actualizar las preferencias de suscripción*|LIST:ADDRESSLINE|*